• Explore /
  • Poster
  • / A novel platform to enrich for tumor-specific T cells in non–small-cell lung cancer.

A novel platform to enrich for tumor-specific T cells in non–small-cell lung cancer.

Abstract Poster

Authors

null

Stephanie J Hachey

ImmunoTarget Therapeutics, Inc., Irvine, CA

Stephanie J Hachey , Alexander G Forsythe , Ali Mahtabifard , Hari B. Keshava , Christopher C.W. Hughes

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Developmental Therapeutics—Immunotherapy

Track

Developmental Therapeutics—Immunotherapy

Sub Track

Cellular Immmunotherapy

Citation

J Clin Oncol 41, 2023 (suppl 16; abstr 2556)

DOI

10.1200/JCO.2023.41.16_suppl.2556

Abstract #

2556

Poster Bd #

398

Abstract Disclosures

Similar Posters

First Author: Jiefei Han

Poster

2023 ASCO Annual Meeting

Large-scale transcriptomic profiling of the tumor immune microenvironment in <em>ALK</em>+ lung cancer.

Large-scale transcriptomic profiling of the tumor immune microenvironment in ALK+ lung cancer.

First Author: Vincent K. Lam

First Author: Xuanyi Li

First Author: Marcelo Vailati Negrao